REGENXBIO Inc.
DE ˙ DB ˙ US75901B1070
6,20 € ↓ -0,10 (-1,59%)
2026-06-02
DEL PRIS
SecurityDE:RB0 / REGENXBIO Inc.
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership244 shares
Latest Disclosed Value $ 2,045
IFP Advisors, Inc reports 61.21% decrease in ownership of RB0 / REGENXBIO Inc.

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 244 shares of REGENXBIO Inc. (DE:RB0) valued at $1,684 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 629 shares of REGENXBIO Inc.. This represents a change in shares of -61.21% during the quarter. The current value of the position is $1,513 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F REGENXBIO cs 75901B107 244 -385 -61.21 2 -77.78 0.0000
2026-02-06 2025-12-31 13F REGENXBIO cs 75901B107 629 284 82.32 9 200.00 0.0002
2026-02-06 2025-09-30 13F/A-1 REGENXBIO cs 75901B107 345 158 84.49 3 200.00 0.0001
2025-12-02 2025-09-30 13F REGENXBIO cs 75901B107 345 158 3 0.0001
2025-07-24 2025-06-30 13F REGENXBIO cs 75901B107 187 163 679.17 2 0.0000
2025-05-05 2025-03-31 13F REGENXBIO cs 75901B107 24 0 0.00 0 0.0000
2025-02-04 2024-12-31 13F REGENXBIO cs 75901B107 24 24 0 0.0000
2024-07-30 2024-06-30 13F REGENXBIO cs 75901B107 0 -125 -100.00 0 -100.00
2024-07-30 2024-03-31 13F REGENXBIO cs 75901B107 125 0 0.00 3 0.00 0.0001
2024-01-09 2023-12-31 13F REGENXBIO cs 75901B107 125 0 0.00 2 0.00 0.0001
2023-10-12 2023-09-30 13F REGENXBIO cs 75901B107 125 0 0.00 2 0.00 0.0001
2023-08-14 2023-06-30 13F/A-1 REGENXBIO cs 75901B107 125 0 0.00 2 -66.67 0.0001
2023-08-04 2023-06-30 13F REGENXBIO cs 75901B107 125 0 7 0.0003
2023-04-18 2023-03-31 13F REGENXBIO cs 75901B107 125 -17 -11.97 7 0.0003
2023-02-07 2022-12-31 13F REGENXBIO cs 75901B107 142 -75 -34.56 0 -100.00 0.0003
2022-11-08 2022-09-30 13F REGENXBIO cs 75901B107 217 17 8.50 14 27.27 0.0004
2022-09-06 2022-06-30 13F/A-1 REGENXBIO cs 75901B107 200 0 0.00 11 0.00 0.0004
2022-09-06 2022-03-31 13F/A-1 REGENXBIO cs 75901B107 200 0 0.00 11 57.14 0.0004
2022-08-08 2022-03-31 13F REGENXBIO INC COM Stock 75901B107 200 0 11 0.0002
2022-01-12 2021-12-31 13F REGENXBIO INC COM Stock 75901B107 200 0 0.00 7 -12.50 0.0001
2021-10-06 2021-09-30 13F REGENXBIO INC COM Stock 75901B107 200 0 0.00 8 0.00 0.0002
2021-07-13 2021-06-30 13F REGENXBIO INC COM Stock 75901B107 200 0 0.00 8 14.29 0.0002
2021-04-30 2021-03-31 13F REGENXBIO INC COM Stock 75901B107 200 0 0.00 7 -22.22 0.0001
2021-01-25 2020-12-31 13F REGENXBIO INC COM Stock 75901B107 200 0 0.00 9 50.00 0.0004
2020-10-29 2020-09-30 13F REGENXBIO INC COM Stock 75901B107 200 0 0.00 6 -14.29 0.0004
2020-08-05 2020-06-30 13F REGENXBIO INC COM Stock 75901B107 200 0 0.00 7 0.00 0.0006
2020-05-12 2020-03-31 13F REGENXBIO INC COM Stock 75901B107 200 -1,064 -84.18 7 -86.54 0.0007
2020-01-17 2019-12-31 13F REGENXBIO INC COM Stock 75901B107 1,264 1,064 532.00 52 642.86 0.0039
2019-11-07 2019-09-30 13F REGENXBIO INC COM Stock 75901B107 200 50 33.33 7 -22.22 0.0005
2019-05-15 2019-03-31 13F REGENXBIO Stock 75901B107 150 -325 -68.42 9 -55.00 0.0012
2019-06-03 2018-12-31 13F/A-10 REGENXBIO INC COM Stock 75901B107 475 0 0.00 20 -44.44 0.0012
2019-01-23 2018-12-31 13F REGENXBIO INC COM Stock 75901B107 475 0 20 0.0012
2019-06-03 2018-09-30 13F/A-9 REGENXBIO INC COM Stock 75901B107 475 0 0.00 36 5.88 0.0015
2018-10-25 2018-09-30 13F REGENXBIO INC COM Stock 75901B107 475 0 36 0.0015
2019-06-03 2018-06-30 13F/A-8 REGENXBIO INC COM Stock 75901B107 475 0 0.00 34 112.50 0.0014
2018-08-07 2018-06-30 13F REGENXBIO INC COM Stock 75901B107 475 0 34
2019-06-03 2018-03-31 13F/A-7 REGENXBIO INC COM Stock 75901B107 475 0 0.00 16 0.00 0.0007
2018-05-09 2018-03-31 13F REGENXBIO INC COM Stock 75901B107 475 0 14
2019-06-03 2017-12-31 13F/A-6 REGENXBIO INC COM Stock 75901B107 475 100 26.67 16 33.33 0.0007
2018-01-24 2017-12-31 13F REGENXBIO INC COM Stock 75901B107 475 100 16
2017-10-30 2017-09-30 13F REGENXBIO INC COM Stock 75901B107 375 375 150.00 12 33.33 0.0005
2016-08-22 2016-06-30 13F REGENXBIO Stock 75901B107 0 -150 -100.00 0 -100.00
2019-06-03 2016-03-31 13F/A-1 REGENXBIO Stock 75901B107 150 150 9 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.